I pazienti affetti da rari problemi ereditari di intolleranza al galattosio, da deficit totale di lattasi, o da malassorbimento di glucosio-galattosio, non devono assumere questo medicinale. Gli studi ...

Teofillina La somministrazione concomitante di febuxostat 80 mg e teofillina 400 mg in dose singola in soggetti sani ha dimostrato l'assenza di interazione farmacocinetica (vedere paragrafo 4.5).

MAINGEAR will be bringing their pre-configurations to other popular chassis in the future, but the initial move is with the MG-1. Whether an eSports competitor, major content creator or a high ...

Now Neurocrine Bioscience, with Ingrezza and elagolix not far behind it, could become a significant mid-size company within just a few years. Andrew McConaghie 11 April, 2017 ...

Our research team assigns Gold ratings to strategies that they have the most conviction will outperform a relevant index, or most peers, over a market cycle on a risk-adjusted basis. The following ...

Where to read The Apothecary Diaries chapter 80? Maomao as seen in the anime (Image via Toho Animation Studio and OLM) Square Enix's Manga Up! website is the only official way for international ...

Small-cap stocks, valued between $300M and $2B, often yield high growth but are more volatile. Historically, small-cap stocks have outperformed large-caps in bull markets, though they carry higher ...

Today marks the introduction of a new higher energy “price cap” will increase the average household’s fuel bills to £1,849 a year. This is an increase of 6.4pc, or £111 more a year, ...

Read Less Introduced by market regulator Ofgem in 2019, the energy price cap sets the maximum amount that energy suppliers are permitted to charge per kWh of gas and electricity (known as the ...

Take the impressive, class-leading MG4, one of MG’s ‘new generation’ cars, and compare it with the old HS. This is a car that was well off the pace of the best family SUVs, but partly ...

Competition to Austedo and Xenazine is also looming from Neurocrine Biosciences, whose VMAT2 drug Ingrezza (valbenazine) is already approved to treat tardive dyskinesia with a phase 3 readout in ...